Target intelligence / Profile preview

Plasmodium mitochondrial cytochrome bc1 complex

Molecular classification
Enzyme, Electron transport chain complex, Mitochondrial respiratory complex, Oxidoreductase
01

Overview

The Plasmodium mitochondrial cytochrome bc1 complex (complex III) is an essential multisubunit enzyme in the parasite's mitochondrial electron transport chain, responsible for transferring electrons from ubiquinol to cytochrome c and generating a proton gradient across the inner mitochondrial membrane, which supports ATP synthesis and is crucial for the oxidative recycling of ubiquinone. This function is vital for dihydroorotate dehydrogenase (DHODH) activity and de novo pyrimidine biosynthesis in Plasmodium, making the complex an established and validated antimalarial drug target. Inhibition of the bc1 complex by antimalarials such as atovaquone leads to blockade of electron transport, collapse of the mitochondrial membrane potential, and lethal impairment of pyrimidine synthesis pathways. Despite its validated target status, resistance often arises rapidly through point mutations in the cytochrome b subunit or via genetic changes affecting alternative metabolic pathways, which presents significant therapeutic challenges.

Other names
Plasmodium cytochrome bc1 complexPlasmodium complex IIIPlasmodium mitochondrial complex IIICytochrome bc1Cyt bc1
02

Mechanism of action

Inhibition of electron transfer from ubiquinol to cytochrome c, leading to collapse of mitochondrial membrane potential and block of de novo pyrimidine synthesis, causing parasite death. Competitive or non-competitive binding at quinone binding sites (Qo and Qi sites).

03

Biological functions

Electron transportGeneration of proton gradient (proton motive force)Support of de novo pyrimidine synthesis via dihydroorotate dehydrogenase activityATP synthesis (indirectly in some life stages of Plasmodium)
04

Disease associations

Infection (essential in the life cycle of Plasmodium spp., the causative agents of malaria)
05

Safety considerations

Host cytotoxicity, as complex III is conserved between human/animal and parasite mitochondria, potentially limiting the therapeutic windowRapid development of drug resistance through point mutations or gene amplificationsUse of drugs targeting this complex can select for panresistant parasite strains
06

Interacting drugs

Atovaquone

5 more in the full profile.

07

Biomarkers

Mutations in the cyt b gene (e.g., specific point mutations conferring atovaquone resistance)Copy number variation or SNPs in pfdhodh gene, which can mediate resistance to bc1 and DHODH inhibitors

Beyond the preview

Go deeper on Plasmodium mitochondrial cytochrome bc1 complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium mitochondrial cytochrome bc1 complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call